Basic Information
Basic information for CCDC26-220-17aa
Peptide Name CCDC26-220-17aa
Genome Position chr8:129216532-129216582[-]
Species Human
Peptide Sequence MKGGYHNLLGVELILWE
Peptide Length 17
Unique No (CCDC26-202-17aa,CCDC26-214-17aa,CCDC26-218-17aa,CCDC26-219-17aa,CCDC26-221-17aa,CCDC26-222-17aa-2,CCDC26-224-17aa,CCDC26-225-17aa,CCDC26-226-17aa,CCDC26-230-17aa,CCDC26-232-17aa,CCDC26-234-17aa,CCDC26-238-17aa-2,CCDC26-240-17aa,CCDC26-241-17aa,CCDC26-242-17aa,CCDC26-248-17aa,CCDC26-249-17aa,CCDC26-250-17aa,CCDC26-251-17aa,CCDC26-258-17aa,CCDC26-259-17aa,CCDC26-260-17aa,CCDC26-261-17aa,CCDC26-265-17aa,CCDC26-266-17aa,CCDC26-267-17aa,CCDC26-269-17aa,CCDC26-271-17aa,CCDC26-272-17aa,CCDC26-274-17aa,CCDC26-276-17aa,CCDC26-278-17aa)
Grand Average of Hydropathicity 0.2824
Relative Molecular Mass 2260.56
Experimental Evidences 1:m6A
lncRNA ID/Name ENSG00000229140;CCDC26
Transcript ID/Name ENST00000653764;CCDC26-220
Transcript Length 1305
Coding Ability 0.3034
DNA Sequence Corresponding to Peptide ATGAAAGGTGGCTACCATAATCTGTTGGGAGTTGAATTAATCCTCTGGGAG
Experimental Evidences
   m6A
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :